Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease
https://doi.org/10.14412/2074-2711-2013-2398
Abstract
About the Authors
Oleg Semenovich LevinDepartment of Neurology, Russian Medical Academy of Postgraduate Education, Center of Extrapyramidal Diseases
V K Datiyeva
Department of Neurology, Russian Medical Academy of Postgraduate Education, Center of Extrapyramidal Diseases
References
1. <div><p>Левин О.С., Федорова Н.В. Болезнь Паркинсона. M., 2006;256 с.</p><p>Antonini A., Tolosa E., Mizuno Y. et al. A reassessment of risks and benefits of dopamine agonists in Parkinson’s disease. Lancet Neurol 2009;8:929-37.</p><p>Hauser R.A., Rascol O., Korczyn A.D. et al. Ten-year follow-up of Parkinson’s disease patients randomized to initial therapy with ropinirole or levodopa. Mov Dis 2007;22:2409-17.</p><p>Watts R.L., Lyons K.E., Pahwa R. et al. Onset of dyskinesia with adjunct ropinirole pro-longed-release or additional levodopa in early Parkinson’s disease. Mov Dis 2010;25:858-66.</p><p>Pahwa R., Stacy M.A., Factor S.A. Ropinirole 24-hour prolonged release: Randomized, controlled study in advanced Parkinson disease. Neurology 2007;68:1108-15.</p><p>Stocchi F., Giorgi L., Hunter B. et al. PREPARED: Comparison of Prolonged and Immediate Release Ropinirole in Advanced Parkinson’s Disease. Mov Dis 2011;doi:10.1002/mds.23498.</p><p>Голубев В.Л. Лечение болезни Паркинсона в поздней стадии. Пожилой пациент 2010;1(2):3—8.</p><p>Chaudhuri K.R., Martinez-Martin P., Rolfe K.A. et al. Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson’s disease. Eur J Neurology 2011;doi:10.1111/j.1468—1331.</p><p>Lyons K.E., Pahwa R. An Open-Label Conversion Study of Pramipexole to Ropinirole Prolonged Release in Parkinson’s Disease. Mov Dis 2009;24:2121-7.</p><p>Weintraub D., Koester J., Potenza M.N. et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010;67:589.</p></div><br />
Review
For citations:
Levin O.S., Datiyeva V.K. Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease. Neurology, Neuropsychiatry, Psychosomatics. 2013;5(1):46-49. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2398
Views: 1068
Email this article 